Home > Boards > US Listed > Medical - Drugs > AVEO Pharmaceuticals, Inc. (AVEO)

Omg Harry and today had nothing to do

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Gungadin1 Member Profile
 
Followed By 1
Posts 466
Boards Moderated 0
Alias Born 07/17/19
160x600 placeholder
AVEO Oncology Announces Appointment of Scarlett Spring to its Board of Directors Business Wire - 11/19/2019 7:00:00 AM
AVEO Announces Presentation of Updated OS and Subgroup Data from Phase 3 TIVO-3 Trial of Tivozanib in Renal Cell Carcinoma Business Wire - 11/18/2019 6:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/12/2019 7:16:33 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/12/2019 7:15:55 AM
AVEO Reports Third Quarter 2019 Financial Results and Provides Business Update Business Wire - 11/12/2019 7:00:00 AM
AVEO Oncology & Biodesix Announce Initiation of the CyFi-2 Study, a Phase 2 Randomized Study of Ficlatuzumab in Combination w... Business Wire - 11/7/2019 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/5/2019 7:02:44 AM
AVEO Oncology Announces Regulatory Update for Tivozanib in Renal Cell Carcinoma Business Wire - 11/4/2019 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/3/2019 9:12:29 AM
AVEO Oncology Announces Initiation of Enrollment in Phase 1b/2 Study of FOTIVDA® (tivozanib) in Combination with IMFINZI® (... Business Wire - 9/30/2019 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/27/2019 7:24:47 AM
AVEO Oncology to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference Business Wire - 9/26/2019 7:00:00 AM
AVEO Oncology & EUSA Pharma Announce Presentation of Final PFS Results from Phase 2 Portion of the TiNivo Study in Renal Cell... Business Wire - 9/23/2019 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/17/2019 5:23:52 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/12/2019 4:11:14 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/10/2019 9:44:00 AM
AVEO Oncology Announces Updated Overall Survival Hazard Ratio of 0.99 in Phase 3 TIVO-3 Trial of Tivozanib in Renal Cell Carc... Business Wire - 9/10/2019 6:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/27/2019 5:26:52 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/8/2019 4:05:34 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/8/2019 7:06:22 AM
AVEO Reports Second Quarter 2019 Financial Results and Provides Business Update Business Wire - 8/8/2019 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/1/2019 6:16:14 AM
Kyowa Kirin Buys Back Tivozanib Non-Oncology Rights from AVEO Oncology Business Wire - 8/1/2019 6:00:00 AM
Amended Statement of Changes in Beneficial Ownership (4/a) Edgar (US Regulatory) - 6/14/2019 8:03:55 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/13/2019 5:02:14 PM
Gungadin1   Wednesday, 10/09/19 01:45:33 AM
Re: harry crumb post# 4935
Post # of 5114 
Omg Harry and today had nothing to do with the market moving down as a whole? I'm set to refill back in the 60s kill load up for the big hike up.but if it goes down now it will just be following the maarkwtbtrend liike allmostvevery other stock did

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist